Prescription Drug Abuse

The summary for the Prescription Drug Abuse Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the government agency that is offering this grant.
Federal Grant Title: Prescription Drug Abuse
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-04-110
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announcement for details.
Posted Date: Jun 21, 2004
Creation Date: Jun 21, 2004
Archive Date: Feb 02, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Grant Description
This PA supersedes PA-01-048, "Prescription Drug Abuse," issued on February 12, 2001 in the NIH Guide for Grants and Contracts at http://grants.nih.gov/grants/guide/pa-files/PA-01-048.html. In revising and reissuing this PA, NIDA continues to encourage research aimed at understanding and reducing prescription drug abuse while supporting appropriate medical use of therapeutic agents with abuse liability. To promote the Nations health, research is needed to understand the factors contributing to prescription drug abuse, to characterize the adverse medical, behavioral, and social consequences associated with this abuse, and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address this issue are encouraged across a broad range of experimental approaches including basic, clinical, epidemiological, prevention, and treatment studies.
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-04-110.html http://grants.nih.gov/grants/guide/pa-files/PA-04-110.html
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)
Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)
Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01)
Effects of Cannabis Use and Cannabinoids on the Developing Brain (R21)
Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Revisions to Add Biomedical Big Data Training to Active NLM Institutional Training Grants ...
Revisions to Add Biomedical Big Data Training to Active Institutional Training Grants (T32...
Predoctoral Training in Biomedical Big Data Science (T32)
Targeting Co-dependent Molecular Pathways in Oral Cancer (U01)
Enabling Resources for Pharmacogenomics (R24)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com